Ifoxa®, NanoAlvand latest offering for chemotherapy protocols with improved side effect profile of patients

NanoAlvand company is a leading producer of high-quality anti-cancer drugs, dedicated to providing top-notch pharmaceuticals to support patients. We have proudly introduced injectable lyophilized powder forms of ifosfamide in 1 gram and 2 grams doses into the Iranian pharmaceutical market. Ifosfamide, an essential drug listed by the World Health Organization, has been widely used in cancer treatment protocols. 

The newly approved lyophilized powder form offers a superior side effect profile, reducing the risk of dangerous complications such as encephalopathy. This advancement demonstrates NanoAlvand's commitment to improving patient care and treatment outcomes.